Approach towards C12 oxo analogues of the side chain of pumiliotoxin B/allopumiliotoxin 339A and B
摘要:
A route towards the synthesis of analogues of pumiliotoxin and allopumiliotoxin side-chain is described. The C I 5,C 16 diol was introduced by asymmetric dihydroxylation using AD-mix beta of C10,C17 enynone intermediate 14, or of C13,C17 precursor 17, or by using a chiron-based route from 24. The trisubstituted alkene functionality was established using arylthio conjugate addition to ynones 16 and 27, followed by a copper-catalyzed stereoretentive reaction with methylmagnesium bromide. The approach enables access to C12 oxo systems and offers an approach towards new C14 analogues. (C) 2002 Elsevier Science Ltd. All rights reserved.
Different α-alkoxy and α,β-di-alkoxy substituted aldehydes have been submitted to the catalytic action of the oxynitrilases from almond (PaHNL) or from Hevea brasiliensis (HbHNL), in order to explore the possibility of using these enzymes for the preparation of complex cyanohydrins. The selectivity of both enzymes towards these compounds was found to be largely dependent on the substitutents, being
[EN] 4,6-SUBSTITUTED-PYRAZOLO[1,5-a]PYRAZINES AS JANUS KINASE INHIBITORS<br/>[FR] PYRAZOLO[1,5-A] PYRAZINES SUBSTITUÉES EN 4,6 EN TANT QU'INHIBITEURS DE LA JANUS KINASE
申请人:ARRAY BIOPHARMA INC
公开号:WO2016090285A1
公开(公告)日:2016-06-09
Compounds of Formula I: and stereoisomers and pharmaceutically acceptable salts and solvates thereof in which R1, R2, R3 and R4 have the meanings given in the specification, are inhibitors of one or more JAK kinases and are useful in the treatment of JAK kinase-associated diseases and disorders, such as autoimmune diseases, inflammatory diseases, rejection of transplanted organs, tissues and cells, as well as hematologic disorders and malignancies and their co-morbidities.
The present application provides compounds, including all stereoisomers, solvates, prodrugs and pharmaceutically acceptable forms thereof according to Formula I. Additionally, the present application provides pharmaceutical compositions containing at least one compound according to Formula I and optionally at least one additional therapeutic agent. Finally, the present application provides methods for treating a patient suffering from an MCHR-1 modulated disease or disorder such as, for example, obesity, diabetes, depression or anxiety by administration of a therapeutically effective dose of a compound according to Formula I
where R
1
, R
1a
, R
1b
, A, R
3
, R
4
, R
5
, R5
b
and R
6
are as defined herein.
Selective Monoalkylation of Acyclic Diols by Means of Dibutyltin Oxide and Fluoride Salts.
作者:Nobuo NAGASHIMA、Masaji OHNO
DOI:10.1248/cpb.39.1972
日期:——
Fluoride anion was found to promote monoalkylation reaction of diols by the stannylene acetal method, and selective monoalkylation of various acyclic diols was accomplished in good yields under mild conditions by employing this new method. Functional groups such as carboxylic acid ester, carboxamide, carbamate, nitrile, alkyl chloride, and ether were not affected under the reaction conditions.
Enantioselective sensing of insect pheromones in water
作者:Briana L. Hickey、Junyi Chen、Yunfan Zou、Adam D. Gill、Wenwan Zhong、Jocelyn G. Millar、Richard J. Hooley
DOI:10.1039/d1cc05540b
日期:——
cavitands and cationic dyes has been shown to optically sense insectpheromones at micromolar concentration in water. Machine learning approaches were used to optimize the most effective array components, which allows differentiation between small structural differences in targets, including between different diastereomers, even though the pheromones have no innate chromophore. When combined with chiral additives